Fridericia chica
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Fridericia chica |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Fridericia Chica |
| Ipni Id | 77142115-1 |
| Plant Name | Fridericia Chica |
| Genus Tax Id | 354074 |
| Disease Name | Kidney failure, Stomach cancer, Alzheimer disease, Renal cell carcinoma, Parkinsonism, Ovarian dysfunction, Spinal cord/cranial nerve neoplasm, Chronic kidney disease, Metastatic digestive system neoplasm, Metabolic disorder, Multiple myeloma, Acute diabete complication, Rheumatoid arthritis, Digestive organ benign neoplasm, Nutritional deficiency, Melanoma, Glaucoma, Malignant digestive organ neoplasm, Mineral deficiency, Solid tumour/cancer, Unspecified viral infection of unspecified site, Inborn metabolism deficiency, Myelodysplastic syndrome, Influenza, Atopic eczema, Pain, unspecified, Inflammatory arthropathy, Acute myeloid leukaemia, Chronic arterial occlusive disease, Fungal infection, Psoriasis, Non-small cell lung cancer, Liver cancer, Diabetes mellitus, type unspecified, Osteosarcoma, Brain cancer, Coronary thrombosis, Malignant haematopoietic neoplasm, Blood-forming organ disease, Colorectal cancer, Acquired hypermelanosis, Follicular lymphoma, Pancreatic cancer, Pleomorphic sarcoma, Chronic pain, Head and neck cancer, Bladder cancer, Liver disease, Lung cancer, Indeterminate colitis, Mature B-cell lymphoma, Colon cancer, Inborn purine/pyrimidine/nucleotide metabolism error, Gout, Liposarcoma, Endometrial cancer, Neuropathy, Human immunodeficiency virus disease, Nasopharyngeal cancer, Mature B-cell leukaemia, Breast cancer, Postoperative inflammation, Extraocular muscle disorder, Transplant rejection, Oesophagitis, Chronic myelomonocytic leukaemia, Type 2 diabetes mellitus, Metastatic lymph node neoplasm, Hypopharyngeal cancer, Thrombocytopenia, Cerebral ischaemia, Leiomyosarcoma, Unspecific substance harmful effect, Ovarian cancer, Duodenal ulcer, Pituitary gland disorder, Thyroid cancer, Ischemia, Prostate cancer, Gastrointestinal stromal tumour, Lupus erythematosus, Autoimmune disease, Bacterial infection, Schizophrenia, Cardiovascular disease, Cervical cancer, Metastatic liver/bile duct neoplasm, Myeloproliferative neoplasm, Parasitic infection, Multiple sclerosis, Epidermal dysplasias, Angina pectoris, Hyper-lipoproteinaemia, Diffuse large B-cell lymphoma, Irritable bowel syndrome, Skin postprocedural disorder, Lip/oral cavity/pharynx neoplasm, Ureteral cancer, Asthma, Idiopathic interstitial pneumonitis, Essential hypertension, Synthesis disorder, Carcinoid syndrome, Seborrhoeic dermatitis, Ocular cancer, Peritoneal cancer, Acquired hypomelanotic disorder, Pediculosis, Myotonic disorder, Mild neurocognitive disorder, Unspecific body region injury, Bleeding disorder, Intracerebral haemorrhage, Esophageal cancer, Bone/articular cartilage neoplasm, Encephalopathy, Non-alcoholic fatty liver disease, Acute/subacute hepatic failure, Dyslipidemia, Filariasis, Dementia, Retinopathy, Diabetic foot ulcer, Thyrotoxicosis, Autism spectrum disorder, Muscular dystrophy, Hyperlipidemia, Thrombosis, Christmas disease, Myasthenia gravis, Cushing syndrome, Fragile X chromosome, Malignant mesenchymal neoplasm, Motor neuron disease, Venous thromboembolism, Fallopian tube cancer, Low bone mass disorder, Coagulation defect, Heart failure, Skin and skin-structure infection, Biliary tract cancer, Endometriosis, Ischaemic/haemorrhagic stroke, Mature T-cell lymphoma, Myocardial infarction, Peroxisomal disease, Transplanted organ/tissue, Deep vein thrombosis, Synovial sarcoma, BCR-ABL1-negative chronic myeloid leukaemia, Oesophageal/gastroduodenal disorder, Female pelvic pain, Substance abuse, Phakomatoses/hamartoneoplastic syndrome, Insomnia, Autonomic nervous system disorder, Hepatitis virus infection, Ischemic heart disease, Parasitic worm infestation, Supraventricular tachyarrhythmia, Genetic prion disease, Testicular cancer, Cerebral ischaemic stroke, Multiple structural anomalies syndrome, Cataract, Urethral cancer, Metastatic biliary tract neoplasms, Inborn lipid metabolism error, Metastatic malignant neoplasm, Mastocytosis, Crohn disease, Attention deficit hyperactivity disorder, Coronavirus infection, Choreiform disorder, Muscular atrophy, Malaria, Obesity, Spina bifida, unspecified, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Neoplasms, Kidney failure, unspecified, Ageing associated decline in intrinsic capacity, Other specified infectious meningitis not elsewhere classified, Type1diabetesmellitus, Chronic kidney disease, stage unspecified, Macular degeneration, Harmful effects of drugs, medicaments or biological substances, not elsewhere classified, Unspecified malignant neoplasms of unspecified sites, HIV-infected patients with tuberculosis, Lichen planus, coronary artery disease, Severe acute respiratory syndrome, COVID-19, Ischaemic heart diseases, unspecified, Porokeratoses, Cutaneous T-cell lymphoma, NOS, Depressive disorders, unspecified, Osteoarthritis, Osteoarthritis of knee, Disorders of cholesterol synthesis, Anaplastic large cell lymphoma, NOS, Cleft palate, Peripheral T-cell lymphoma, not otherwise specified, Pulmonary hypertension, Becker muscular dystrophy, Male infertility, Malignant neoplasms of retroperitoneum, Cleft lip, Gastro-oesophageal reflux disease, Adenocarcinoma of prostate, Congenital aplastic anaemia, Anterior uveitis, Carpal tunnel syndrome, Chronic obstructive pulmonary disease, Recurrent pregnancy loss, Iron deficiency anaemia, Pleural mesothelioma, Anemia, Haemorrhage, not elsewhere classified, Rectum cancer, Tension-type headache, Systemic lupus erythematosus, Focal/segmental autonomic disorder, Polycystic ovary syndrome, Coronary atherosclerosis, Sickle-cell disorder, Nephrocalcinosis, Schizophrenia or other primary psychotic disorders, unspecified, Pulmonary alveolar proteinosis, Glioma, malignant, Breast in situ carcinoma, Cholelithiasis, Epilepsy/seizure, Mycosis fungoides, Malignant neoplasms of other or unspecified parts of mouth, Noninfectious erosive or ulcerative disorders of oral mucosa, Oral mucositis, Sezary syndrome, Neoplasms of unknown behaviour of breast, Chronic hepatitis C, Cystic fibrosis, Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Inflammatory bowel diseases, unspecified, Zika virus disease, Osteoarthritis, unspecified, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Malignant neoplasms of bladder, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Pneumonia due to Pseudomonasaeruginosa, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic sclerosis, Chronic rhinosinusitis, Malignant neoplasms of thyroid gland, unspecified, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Dilated cardiomyopathy, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Ebola virus disease, Malignant neoplasms of adrenal gland, Malignant neoplasm of pancreas, Lyme borreliosis, Gliomas of brain |
| Species Name | Fridericia chica |
| Genus Name | Fridericia |
| Species Tax Id | 353936 |
| Disease Id | GB60-GB6Z, 2B72, 8A20, 2C90, 8A00, 5A80, 2A02, GB61, 2D8Y, 5C50-5D2Z, 2A83, 5A2Y, FA20, 2.00E+92, 5B50-5B71, 2C30, 9C61, 2C11, 5B5K, 2A00-2F9Z, 1D9Z, 5C50-5C59, 2A37, 1E30-1E32, EA80, MG3Z, FA2Z, 2A60, BD4Z, 1F29-1F2F, EA90, 2C25, 2C12, 5A14, 2B51, 2A00, BA43, 2B33, 3C0Z, 2B91, ED60, 2A80, 2C10, 2B54, MG30, 2D42, 2C94, DB90-DB9Z, DD72, 2A85, 2B90, 5C55, FA25, 2B59, 2C76, 8C0Z, 1C60-1C62, 2B6B, 2A82, 2C60-2C6Y, 1A00-CA43, 9C82, NE84, DA24, 2A40, 5A11, 2D60, 2B6D, 3B64, 8B1Z, 2B58, NE6Z, 2C73, DA63, 5A60-5A61, 2D10, 8B10-8B11, 2C82, 2B5B, 4A40, 4A40-4A45, 1A00-1C4Z, 6A20, BA00-BE2Z, 2C77, 2D80, 2A20, 1D0Y-1G2Z, 8A40, EK90, BA40, 5C80, 2A81, DD91, EL8Y, 2B6E, 2C92, CA23, CB03, BA00, 5C52-5C59, 5B10, EA81, 2D00-2D07, 2C51, ED63, 1G00, 8C71, 6D71, ND56, GA20-GA21, 8B00, 2B70, 2F7B, 8.00E+47, DB92, DB91, 5C80-5C81, 1F66, 6D80-6D8Z, 9B71, BD54, 5A02, 6A02, 8C70, DB61-GB90, 3B11, 8C6Y, 5A70, LD55, 2B5D-2B5Y, 8B60, BD72, 2C74, FB83, 3B10, BD10-BD1Z, 1F28-1G0Z, 2C17, GA10, 8B20, 2A90, BA41-BA43, 5C57, QB63, BD71, 2B5A, 2A41, DD90, GA34, 6C40, LD2D, 7A00-7A0Z, 8D87, 1E50-1E51, BA40-BA6Z, 1F90, BC81, 8.00E+02, 2C80, 8B11, LD2F, 9B10, 2C93, 2C14-2C17, 5C52, 2D50-2E09, 2A21, DD70, 6A05, 1D92, 8A01, 8B61, 1F40-1F45, 5B80-5B81, LA02.Z, 1C62.Z, 2, GB6Z, MG2A, 1D01.Y, 5A10, GB61.Z, 9B75, NE60, 2D4Z, 1B10-1B14, EA91, BA8Y-BA8Z, 1D65, 1D6Y, BA6Z, ED52, XH1951, 6A7Z, FA00-FA05, FA01, 5C52.10, XH1LC0, LA42, 2A90.C, BB01, 8C70.0, GB04, 2C50, LA40, DA22, 2C82.0, 3A70.0, 9A96, 8C10.0, CA22, GA33, 3A00, 2C26, 3A00-3A9Z, MG27, 2B92, 8A81, 4A40.0, 8D8A, 5A80.1, BA80, 3A51, GB57, 6A2Z, CB04.31, XH4RQ3, 2.00E+65, DC11, 8A61-8A6Z, 2B01, 2B66, DA01.1, DA01, XH8HN3, 2F95, 1E51.1, CA25, 6A02.0, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, DD7Z, 1D48, FA0Z, 1D2Z, 2C15, 2C12.01, 1F54, 2B72.0, BC81.3, 2D60.0, 8C71.0, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, CA40.05, 2C12.02, 2C25.Y, GA10.B4, 2C94.2, 1D82, 4A42, CA0A, 2D10.Z, 2C25.0, 2C76.Z, 1D40, BC43.0, 2C27, 2C61, BD1Z, 1C62, 2A00.00, XH6153, 2C80.2, 1D60.01, 2D11, 1C1G, 2A00.0 |
| Family Name | Bignoniaceae |
| Family Tax Id | 24079 |
- 1. (-)-Epitaxifolin (PubChem CID: 712318)
- 2. (1r,3r,6s,8r,11s,12r,15r,16r)-7,7,11,12,16-Pentamethyl-15-[(2s)-6-Methylhept-5-En-2-Yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 162905452)
- 3. (1r,3s,6s)-6-[(1e,3e,5e,7z,9e,11e,13e,15e,17e)-18-[(1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-Nonaenyl]-1,5,5-Trimethyl-7-Oxabicyclo[4.1.0]heptan-3-Ol (PubChem CID: 12358665)
- 4. (1s)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,4s)-4-Hydroxy-2,6,6-Trimethylcyclohex-2-En-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-Nonaenyl]-3,5,5-Trimethylcyclohex-3-En-1-Ol (PubChem CID: 44481270)
- 5. (1s,2r,4as,6ar,6ar,6br,8ar,10s,12ar,14ar,14bs)-1,2,4a,6a,6b,9,9,12a-Octamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14,14a,14b-Hexadecahydropicene-2,10-Diol (PubChem CID: 10478653)
- 6. (1s,2s,4as,6ar,6ar,6br,8ar,10s,12ar,14ar,14bs)-1,2,4a,6a,6b,9,9,12a-Octamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14,14a,14b-Hexadecahydropicene-2,10-Diol (PubChem CID: 14313598)
- 7. (1s,3r,6s)-6-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,4s,6s)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15,17-Nonaenyl]-1,5,5-Trimethylcyclohexane-1,3-Diol (PubChem CID: 162989145)
- 8. (1s,3r,6s,7s,8s,11s,12s,15r,16r)-7-(Hydroxymethyl)-7,12,16-Trimethyl-15-[(2r)-6-Methylheptan-2-Yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 163093755)
- 9. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r)-6-(Hydroxymethyl)hept-6-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 163034995)
- 10. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2r,5r)-5-Hydroxy-6-Methylhept-6-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 14313591)
- 11. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(2s,3r)-3-Hydroxy-6-Methylhept-5-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 163025603)
- 12. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(E,2r)-6-Methoxy-6-Methylhept-4-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 21599950)
- 13. (1s,3r,6s,8r,11s,12s,15r,16r)-15-[(E,2r,6r)-7-Hydroxy-6-Methylhept-4-En-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 162945131)
- 14. (1s,3r,6s,8s,11r,12s,15r,16r)-15-[(2s,6s)-7-Hydroxy-6-Methyl-5-Methylideneheptan-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-Ol (PubChem CID: 162877130)
- 15. (1s,3r,8r,11s,12s,15r,16r)-15-[(2r,6s)-7-Hydroxy-6-Methyl-5-Methylideneheptan-2-Yl]-7,7,12,16-Tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-One (PubChem CID: 100966504)
- 16. (1s,3r,8s,11s,12s,13s,15r,16r)-7,7,13,16-Tetramethyl-15-[(2r)-6-Methylhept-5-En-2-Yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecane (PubChem CID: 162959957)
- 17. (24s)-Cycloartane-3 (PubChem CID: 14314549)
- 18. (2r)-2,3-Dihydroxypropyl (9z)-Octadec-9-Enoate (PubChem CID: 11451146)
- 19. (2r,3r)-2-(3,4-Dihydroxyphenyl)-3,4-Dihydro-5,7-Dihydroxy-2h-1-Benzopyran-3-Yl Beta-D-Glucopyranoside (PubChem CID: 21626710)
- 20. (2r,3s)-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-2,3-Dihydrochromen-4-One (PubChem CID: 162993993)
- 21. (2r,3s,4s,5r,6r)-2-(Hydroxymethyl)-6-[(1r,6s)-6-Nonylcyclohex-2-En-1-Yl]oxyoxane-3,4,5-Triol (PubChem CID: 162937063)
- 22. (2r,6r)-2-Methyl-3-Methylidene-6-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]heptanoic Acid (PubChem CID: 101286242)
- 23. (2r,6r)-6-[(1r,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 163038821)
- 24. (2r,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 101286241)
- 25. (2r,6s)-2-Methyl-3-Methylidene-6-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]heptanoic Acid (PubChem CID: 163011701)
- 26. (2r,6s)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 163038823)
- 27. (2r,6s,10s)-2,6,10-Trimethyldodecanoic Acid (PubChem CID: 162960174)
- 28. (2r,6s,7ar)-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1s,4r,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]-6,11,15-Trimethylheptadeca-2,4,6,8,10,12,14,16-Octaen-2-Yl]-4,4,7a-Trimethyl-2,5,6,7-Tetrahydro-1-Benzofuran-6-Ol (PubChem CID: 162861646)
- 29. (2r,7ar)-4,4,7a-Trimethyl-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-6,11,15-Trimethyl-17-(2,6,6-Trimethylcyclohexen-1-Yl)heptadeca-2,4,6,8,10,12,14,16-Octaen-2-Yl]-2,5,6,7-Tetrahydro-1-Benzofuran (PubChem CID: 163004300)
- 30. (2s)-2-[[4-[(2-Amino-4-Oxo-1h-Pteridin-6-Yl)methylamino]benzoyl]amino]pentanedioic Acid (PubChem CID: 6037)
- 31. (2s,3r,4s,5s,6r)-3,5-Dimethoxy-6-(Methoxymethyl)oxane-2,4-Diol (PubChem CID: 13887303)
- 32. (2s,3r,4s,5s,6r)-6-(Hydroxymethyl)-3,4-Dimethoxyoxane-2,5-Diol (PubChem CID: 163044429)
- 33. (2s,4r,10s)-2,10-Dimethyl-6-Methylidenedodecane-1,4-Diol (PubChem CID: 162934688)
- 34. (2s,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methyl-3-Methylideneheptanoic Acid (PubChem CID: 163185187)
- 35. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[2,3,6-Tris-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 101352486)
- 36. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[2-O-(4-Hydroxybenzoyl)-6-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 102076688)
- 37. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[6-O-(4-Hydroxybenzoyl)-2-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 102076687)
- 38. (3,4-Dihydroxyphenyl)[2,4,6-Trihydroxy-3-[6-O-(4-Hydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 163052741)
- 39. (3r,4ar,6ar,6br,8ar,12as,14as,14br)-4,4,6a,6b,8a,11,11,14b-Octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-Tetradecahydropicen-3-Ol (PubChem CID: 163069310)
- 40. (3r,5r)-5-[(2r)-2,6-Dimethylheptyl]-3-Ethyloxolan-2-One (PubChem CID: 162996247)
- 41. (3s)-Beta-Cryptoxanthin (PubChem CID: 44554791)
- 42. (3s,3as,5ar,5br,7as,9s,11r,11ar,11bs,13ar,13bs)-3-(2-Hydroxypropan-2-Yl)-5a,5b,8,8,11a,13b-Hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-Hexadecahydrocyclopenta[A]chrysene-9,11-Diol (PubChem CID: 14314555)
- 43. (3s,4ar,6ar,6bs,8ar,11r,12s,12as,14ar,14br)-4,4,6a,6b,8a,11,12,14b-Octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-Tetradecahydro-1h-Picen-3-Ol (PubChem CID: 10836206)
- 44. (3s,4ar,6ar,6bs,8ar,12as,14ar,14br)-4,4,6a,6b,8a,11,11,14b-Octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-Tetradecahydropicen-3-Ol (PubChem CID: 12358398)
- 45. (3s,5r,9r,10s,13r,14r,17r)-17-[(2r,5r)-5-Ethyl-6-Methylheptan-2-Yl]-3-Hydroxy-10,13-Dimethyl-1,2,3,4,5,6,9,12,14,15,16,17-Dodecahydrocyclopenta[A]phenanthren-11-One (PubChem CID: 162992686)
- 46. (4-Hydroxyphenyl)[2,4,6-Trihydroxy-3-[2,3,6-Tris-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]phenyl]methanone (PubChem CID: 162986904)
- 47. (4ar,6ar,6ar,6br,8as,11r,12s,12ar,14ar,14br)-11-Hydroxy-4,4,6a,6b,8a,11,12,14b-Octamethyl-2,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-Tetradecahydro-1h-Picen-3-One (PubChem CID: 162959924)
- 48. (4ar,6ar,6ar,6br,8as,11s,12s,12as,14ar,14br)-11-Hydroxy-4,4,6a,6b,8a,11,12,14b-Octamethyl-2,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-Tetradecahydro-1h-Picen-3-One (PubChem CID: 101290252)
- 49. (4ar,6ar,6as,6br,8ar,10r,12ar,14br)-10-Hydroxy-2,2,6a,6b,9,9,12a-Heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-Tetradecahydropicene-4a-Carbaldehyde (PubChem CID: 162939236)
- 50. (4ar,6as,6ar,6br,8ar,11r,12s,12ar,14ar,14br)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,4a,5,6,6a,7,8,9,10,11,12,12a,13,14,14a-Hexadecahydropicen-3-One (PubChem CID: 15427884)
- 51. (4ar,6as,6ar,6br,8as,11r,12r,12as,14ar,14br)-11-Hydroxy-4,4,6a,6b,8a,12,14b-Heptamethyl-1,2,4a,5,6,6a,7,8,9,10,11,12,12a,13,14,14a-Hexadecahydropicen-3-One (PubChem CID: 162962891)
- 52. (5r,8r,9r,10r,13r,14r,17s)-17-[(2s,5r)-5-[(2s)-1,2-Dihydroxypropan-2-Yl]-2-Methyloxolan-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 162995360)
- 53. (5r,8r,9s,10r,13r,14r,17s)-17-[(2r,5r)-5-[(2s)-1,2-Dihydroxypropan-2-Yl]-2-Methyloxolan-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 162995359)
- 54. (5s,6r)-Beta-Carotene 5,6-Epoxide (PubChem CID: 9548874)
- 55. (6r)-6-[(1s,3r,6r,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162956741)
- 56. (E,4r,6r)-4-Hydroxy-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 100966505)
- 57. (E,4s,6r)-4-Hydroxy-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 100966506)
- 58. (E,5r,6s)-5-Hydroxy-6-[(1s,3r,6r,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162937479)
- 59. (E,5r,6s)-5-Hydroxy-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162937480)
- 60. (E,6r)-2-(Hydroxymethyl)-6-[(1s,3r,6r,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 14314564)
- 61. (E,6r)-2-Methyl-6-[(1s,3r,8r,11s,12s,13s,15r,16r)-7,7,13,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 162939569)
- 62. (E,6r)-2-Methyl-6-[(1s,3r,8s,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 14034475)
- 63. (E,6r)-6-[(1s,3r,6s,8r,11s,12s,13s,15r,16r)-6-Hydroxy-7,7,13,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162945699)
- 64. (E,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enal (PubChem CID: 14314541)
- 65. (E,6r)-6-[(1s,3r,6s,8s,11r,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enal (PubChem CID: 162961000)
- 66. (E,6s)-2-Methyl-6-[(1s,3r,8s,11s,12s,15r,16r)-7,7,12,16-Tetramethyl-6-Oxo-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-Enoic Acid (PubChem CID: 163065451)
- 67. (E,6s)-6-[(1s,3r,6r,8s,11r,12s,15r,16r)-6-Hydroxy-7,7,12,16-Tetramethyl-15-Pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-Methylhept-2-Enoic Acid (PubChem CID: 162956738)
- 68. (Inverted Exclamation Marka)-Emodin Bianthrone (PubChem CID: 12096290)
- 69. (Z)-5-(Heptadec-2-En-1-Yl)resorcinol (PubChem CID: 126457709)
- 70. 1,3,6,7-Tetrahydroxy-2-[(2r,3s,4s,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]xanthen-9-One (PubChem CID: 124461561)
- 71. 1,3,6,7-Tetrahydroxy-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyxanthen-9-One (PubChem CID: 5319258)
- 72. 1,3,6,7-Tetrahydroxy-4-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyxanthen-9-One (PubChem CID: 162901555)
- 73. 1,3-Dielaidin (PubChem CID: 5316908)
- 74. 1,6,7-Trihydroxy-3-Methoxy-2-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyxanthen-9-One (PubChem CID: 5318081)
- 75. 2,3,4,6-Tetra-O-Methyl-Alpha-D-Glucose (PubChem CID: 111162)
- 76. 2,3,6-Tri-O-Methyl-Beta-D-Glucopyranose (PubChem CID: 448683)
- 77. 2,3-Di-O-Methyl-Alpha-D-Glucopyranose (PubChem CID: 14211992)
- 78. 2-Monoolein (PubChem CID: 5319879)
- 79. 24-Methylenecycloartanol (PubChem CID: 94204)
- 80. 24-Methylenecycloartanone (PubChem CID: 14635659)
- 81. 27-Hydroxymangiferolic Acid (PubChem CID: 45269256)
- 82. 27-Hydroxymangiferonic Acid (PubChem CID: 45270932)
- 83. 3,4-Dihydroxybenzoic Acid (PubChem CID: 72)
- 84. 3-[(2r,3s,4r,5s,6s)-3,5-Dihydroxy-6-(Hydroxymethyl)-4-[(2s,3s,4r,5r,6s)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyoxan-2-Yl]oxy-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxychromen-4-One (PubChem CID: 163043399)
- 85. 3-[3,4-Dihydroxy-5-(3,4,5-Trihydroxyphenoxy)carbonylbenzoyl]oxy-4,5-Dihydroxybenzoic Acid (PubChem CID: 162974772)
- 86. 3-Hydroxy-4-Methyl-5-(3,4,5-Trihydroxybenzoyl)oxybenzoic Acid (PubChem CID: 163047252)
- 87. 5-((8z,11z)-Heptadeca-8,11-Dien-1-Yl)resorcinol (PubChem CID: 14235913)
- 88. 5-(Heptadec-12-Enyl)resorcinol (PubChem CID: 5281859)
- 89. 5-[(E)-Heptadec-12-Enyl]benzene-1,3-Diol (PubChem CID: 5318012)
- 90. 5-[(Z)-Heptadec-11-Enyl]benzene-1,3-Diol (PubChem CID: 24802634)
- 91. 5-Hydroxy-3-(4-Hydroxylphenyl)pyrano[3,2-G]chromene-4(8h)-One (PubChem CID: 91356749)
- 92. 6beta-Hydroxystigmast-4-En-3-One (PubChem CID: 9823926)
- 93. 9,19-Cyclolanost-24-Ene-3,26-Diol, (3beta)- (PubChem CID: 134694294)
- 94. 9,19-Cyclolanostan-28-Ol, (4beta)- (PubChem CID: 101670839)
- 95. 9,19-Cyclolanostan-3-One, 26-Hydroxy-24-Methylene-, (25r)- (PubChem CID: 162891806)
- 96. 9-Cis-Violaxanthin (PubChem CID: 5282218)
- 97. [(2s,3r,4s,5r,6s)-2-[3-(3,4-Dihydroxybenzoyl)-2,4,6-Trihydroxyphenyl]-4,5-Dihydroxy-6-[(4-Hydroxybenzoyl)oxymethyl]oxan-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162871723)
- 98. [(3s,5r,8r,9s,10s,13r,14s,17r)-9-Ethyl-4,4,13,14-Tetramethyl-17-[(2r)-6-Methylheptan-2-Yl]-2,3,5,6,7,8,10,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl] Acetate (PubChem CID: 162960071)
- 99. [2,6-Dihydroxy-4-Methoxy-3-[(2s,3r,4r,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]phenyl]-(4-Hydroxy-3-Methoxyphenyl)methanone (PubChem CID: 46206549)
- 100. [2,6-Dihydroxy-4-Methoxy-3-[(2s,3r,4r,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]phenyl]-(4-Hydroxyphenyl)methanone (PubChem CID: 46206548)
- 101. [3-[2,6-Bis-O-(3,4,5-Trihydroxybenzoyl)-I(2)-D-Glucopyranosyl]-2,4,6-Trihydroxyphenyl](4-Hydroxyphenyl)methanone (PubChem CID: 102082135)
- 102. Alpha-Amyrin (PubChem CID: 73170)
- 103. Alpha-D-Galactose (PubChem CID: 439357)
- 104. Alpha-Methylbutyrolactone, (R)- (PubChem CID: 638758)
- 105. Arachidic Acid (PubChem CID: 10467)
- 106. Aubergenone (PubChem CID: 15601418)
- 107. Aurasperone D (PubChem CID: 155008)
- 108. Beta-Amyrin (PubChem CID: 73145)
- 109. Beta-Carotene (PubChem CID: 5280489)
- 110. Beta-Sitosterol (PubChem CID: 222284)
- 111. Cholesterol (PubChem CID: 5997)
- 112. Cianidanol (PubChem CID: 9064)
- 113. Cycloart-23-Ene-3beta,25-Diol (PubChem CID: 5470009)
- 114. Cycloart-23-Ene-3i(2),25-Diol (PubChem CID: 393626)
- 115. Cycloartane-3i(2),25-Diol (PubChem CID: 14314547)
- 116. Cycloartenol (PubChem CID: 92110)
- 117. Cycloartenol Acetate (PubChem CID: 13023741)
- 118. Cycloartenone (PubChem CID: 12305360)
- 119. Dammar-24-En-3-One, 20,26-Dihydroxy-, (24e)- (PubChem CID: 162968264)
- 120. Dammarenediol-I (PubChem CID: 441675)
- 121. Diolein (PubChem CID: 6505653)
- 122. Epicatechin (PubChem CID: 72276)
- 123. Epifriedelanol (PubChem CID: 119242)
- 124. Epigallo Catechin Gallate (PubChem CID: 5276454)
- 125. Erythrodiol (PubChem CID: 101761)
- 126. Ethyl Gallate (PubChem CID: 13250)
- 127. Euxanthone (PubChem CID: 5281631)
- 128. Fisetin (PubChem CID: 5281614)
- 129. Friedelin (PubChem CID: 91472)
- 130. Friedelinol (PubChem CID: 101341)
- 131. Gallic Acid (PubChem CID: 370)
- 132. Gentisein (PubChem CID: 5281635)
- 133. Heptadecanoic Acid (PubChem CID: 10465)
- 134. Hexacontane (PubChem CID: 24318)
- 135. Homomangiferin (PubChem CID: 5491388)
- 136. Hydrogen Cyanide (PubChem CID: 768)
- 137. Isomangiferin (PubChem CID: 5318597)
- 138. Isomangiferolic Acid (PubChem CID: 14034468)
- 139. Isoschisandrolicacid (PubChem CID: 137347660)
- 140. Kaempferol (PubChem CID: 5280863)
- 141. L-Tartaric Acid (PubChem CID: 444305)
- 142. Linoleic Acid (PubChem CID: 5280450)
- 143. Linolenic Acid (PubChem CID: 5280934)
- 144. Lupeol (PubChem CID: 259846)
- 145. Lupeol Acetate (PubChem CID: 92157)
- 146. Maclurin 3-C-Beta-Glucoside (PubChem CID: 101538363)
- 147. Mangiferin (PubChem CID: 5281647)
- 148. Mangiferin 6'-O-Gallate (PubChem CID: 162932599)
- 149. Mangiferolic Acid (PubChem CID: 45270099)
- 150. Mangiferonic Acid (PubChem CID: 14034474)
- 151. Methyl Gallate (PubChem CID: 7428)
- 152. Myristic Acid (PubChem CID: 11005)
- 153. Norathyriol (PubChem CID: 5281656)
- 154. Olean-13(18)-En-11-One (PubChem CID: 15427883)
- 155. Oleanolic Aldehyde (PubChem CID: 10321055)
- 156. Oleic Acid (PubChem CID: 445639)
- 157. Palmitic Acid (PubChem CID: 985)
- 158. Pentadecanoic Acid (PubChem CID: 13849)
- 159. Pentagalloylglucose (PubChem CID: 65238)
- 160. Propyl Benzoate (PubChem CID: 16846)
- 161. Propyl Gallate (PubChem CID: 4947)
- 162. Quercetin (PubChem CID: 5280343)
- 163. Quercitrin (PubChem CID: 5280459)
- 164. Quosp (PubChem CID: 5282166)
- 165. Rhamnetin 3-Galactoside (PubChem CID: 10344991)
- 166. Rhamnetin 3-O- (PubChem CID: 14704554)
- 167. Rubrofusarin (PubChem CID: 72537)
- 168. Rutin (PubChem CID: 5280805)
- 169. Sitogluside (PubChem CID: 5742590)
- 170. Stearic Acid (PubChem CID: 5281)
- 171. Stigmastane-3,6-Diol (PubChem CID: 12070151)
- 172. Taraxerol (PubChem CID: 92097)
- 173. Taraxerone (PubChem CID: 92785)
- 174. Triacontane (PubChem CID: 12535)
- 175. Zeaxanthin, (3s,3's)- (PubChem CID: 21772452)
- 1. Alzheimer's Disease 1
- 2. Anemia
- 3. Arthritis
- 4. Arthritis, Gouty
- 5. Arthritis, Rheumatoid
- 6. Asthma
- 7. Cardiovascular Diseases
- 8. Cataract
- 9. Celiac Disease
- 10. Cholelithiasis
- 11. Cholera
- 12. Coronary Artery Disease
- 13. Crohn Disease
- 14. Cystic Fibrosis
- 15. Dementia
- 16. Diabetes Mellitus
- 17. Diabetes Mellitus, Type 1
- 18. Epilepsy
- 19. Esophagitis
- 20. Filariasis
- 21. Glaucoma
- 22. Hematologic Diseases
- 23. Infertility, Male
- 24. Inflammatory Bowel Diseases
- 25. Influenza, Human
- 26. Liver Neoplasms
- 27. Lupus Erythematosus, Systemic
- 28. Muscular Dystrophies
- 29. Myocardial Infarction
- 30. Obesity
- 31. Osteoarthritis
- 32. Pre-Eclampsia
- 33. Psoriasis
- 34. Scleroderma, Systemic
- 35. Stomatitis
- 36. Thrombocytopenia
Not listed in any formulations.